Oct 28, 2025

Today’s guest is Scott Bradley, VP of AI and Innovation at Novartis. As the eighth largest pharmaceutical company in the world by revenue, Novartis’ medicines reach millions of people worldwide. Their focus on the discovery and development of novel, breakthrough treatments sees them reimagining not just the delivery...

Oct 21, 2025

Today’s guest is Xiong Liu, Director of Data Science and AI at Novartis. Novartis is among the world’s leading pharmaceutical companies, pioneering data and advanced analytics in the pursuit of new medicines and patient outcomes. Xiong joins Emerj Editorial Director Matthew DeMello to examine how generative AI and...

Sep 16, 2025

Clinical trials are growing more complex, and nowhere is that more evident than in oncology and obesity research. As sponsors push for reliable, real-time patient data, the role of electronic clinical outcome assessments (eCOAs) has never been more critical. These tools determine not only how patients report on their...

Aug 5, 2025

Today’s guest is Patricio La Rosa, Head of End-to-End Decision Science in Seed Production Innovation at Bayer Crop Science. Patricio joins the AI in Business podcast to explore how AI is transforming the clinical trial lifecycle, from biomarker discovery to long-term patient engagement. Drawing on his academic...

Jul 14, 2025

Today’s guest is Brad Kennedy, Senior Director of Business Solutions Strategy at Orlando Health — a not-for-profit healthcare organization headquartered in Florida. With years of experience leading innovation and patient experience programs in hospital systems, Brad joins Emerj Managing Editor Matthew DeMello on the...